243 related articles for article (PubMed ID: 29809327)
1. [Molecular and clinical characterization of Colombian patients suffering from type III glycogen storage disease].
Mantilla C; Toro M; Sepúlveda ME; Insuasty M; Di Filippo D; López JÁ; Baquero C; Navas MC; Arias AA
Biomedica; 2018 May; 38(0):30-42. PubMed ID: 29809327
[TBL] [Abstract][Full Text] [Related]
2. Molecular and clinical delineation of 12 patients with glycogen storage disease type III in Western Turkey.
Okubo M; Ucar SK; Podskarbi T; Murase T; Shin YS; Coker M
Clin Chim Acta; 2015 Jan; 439():162-7. PubMed ID: 25451950
[TBL] [Abstract][Full Text] [Related]
3. A founder splice site mutation underlies glycogen storage disease type 3 in consanguineous Saudi families.
Basit S; Malibari O; Al Balwi AM; Abdusamad F; Abu Ismail F
Ann Saudi Med; 2014; 34(5):390-5. PubMed ID: 25827695
[TBL] [Abstract][Full Text] [Related]
4. [Mutation analysis of glycogen debrancher enzyme gene in five Chinese patients with glycogen storage disease type III].
Zhuang TF; Qiu ZQ; Wei M; Huang SZ
Zhonghua Er Ke Za Zhi; 2005 Feb; 43(2):85-8. PubMed ID: 15833157
[TBL] [Abstract][Full Text] [Related]
5. Spectrum of AGL mutations in Chinese patients with glycogen storage disease type III: identification of 31 novel mutations.
Lu C; Qiu Z; Sun M; Wang W; Wei M; Zhang X
J Hum Genet; 2016 Jul; 61(7):641-5. PubMed ID: 26984562
[TBL] [Abstract][Full Text] [Related]
6. A c.3216_3217delGA mutation in AGL gene in Tunisian patients with a glycogen storage disease type III: evidence of a founder effect.
Mili A; Ben Charfeddine I; Amara A; Mamaï O; Adala L; Ben Lazreg T; Bouguila J; Saad A; Limem K; Gribaa M
Clin Genet; 2012 Dec; 82(6):534-9. PubMed ID: 22035446
[TBL] [Abstract][Full Text] [Related]
7. The biallelic novel pathogenic variants in AGL gene in a chinese patient with glycogen storage disease type III.
Wang J; Yu Y; Cai C; Zhi X; Zhang Y; Zhao Y; Shu J
BMC Pediatr; 2022 May; 22(1):284. PubMed ID: 35578201
[TBL] [Abstract][Full Text] [Related]
8. Molecular characterization of glycogen storage disease type III.
Shen JJ; Chen YT
Curr Mol Med; 2002 Mar; 2(2):167-75. PubMed ID: 11949933
[TBL] [Abstract][Full Text] [Related]
9. Molecular and biochemical characterization of a novel intronic single point mutation in a Tunisian family with glycogen storage disease type III.
Ben Rhouma F; Azzouz H; Petit FM; Khelifa MB; Chehida AB; Nasrallah F; Parisot F; Lasram K; Kefi R; Bouyacoub Y; Romdhane L; Baussan C; Kaabachi N; Ben Dridi MF; Tebib N; Abdelhak S
Mol Biol Rep; 2013 Jul; 40(7):4197-202. PubMed ID: 23649758
[TBL] [Abstract][Full Text] [Related]
10. [Molecular genetic analysis of 10 Chinese patients with glycogen storage disease type III].
Wang X; Qiu WJ; Ye J; Han LS; Zhang HW; Jiang LR; Zhang YF; Gu XF
Zhonghua Er Ke Za Zhi; 2009 Jun; 47(6):416-20. PubMed ID: 19951465
[TBL] [Abstract][Full Text] [Related]
11. Genetic analysis and clinical assessment of four patients with Glycogen Storage Disease Type IIIa in China.
Zhang Y; Xu M; Chen X; Yan A; Zhang G; Liu Z; Qiu W
BMC Med Genet; 2018 Apr; 19(1):54. PubMed ID: 29614965
[TBL] [Abstract][Full Text] [Related]
12. Clinical and genetic variability of glycogen storage disease type IIIa: seven novel AGL gene mutations in the Mediterranean area.
Lucchiari S; Fogh I; Prelle A; Parini R; Bresolin N; Melis D; Fiori L; Scarlato G; Comi GP
Am J Med Genet; 2002 May; 109(3):183-90. PubMed ID: 11977176
[TBL] [Abstract][Full Text] [Related]
13. Spectrum of amyloglucosidase mutations in Asian Indian patients with Glycogen storage disease type III.
Perveen S; Gupta N; Kumar M; Kaur P; Chowdhury MR; Kabra M
Am J Med Genet A; 2020 May; 182(5):1190-1200. PubMed ID: 32222031
[TBL] [Abstract][Full Text] [Related]
14. Molecular features of 23 patients with glycogen storage disease type III in Turkey: a novel mutation p.R1147G associated with isolated glucosidase deficiency, along with 9 AGL mutations.
Aoyama Y; Ozer I; Demirkol M; Ebara T; Murase T; Podskarbi T; Shin YS; Gokcay G; Okubo M
J Hum Genet; 2009 Nov; 54(11):681-6. PubMed ID: 19834502
[TBL] [Abstract][Full Text] [Related]
15. Genotype-phenotype correlation in two frequent mutations and mutation update in type III glycogen storage disease.
Shaiu WL; Kishnani PS; Shen J; Liu HM; Chen YT
Mol Genet Metab; 2000 Jan; 69(1):16-23. PubMed ID: 10655153
[TBL] [Abstract][Full Text] [Related]
16. Intron retention is among six unreported AGL mutations identified in Malaysian GSD III patients.
Abdullah IS; Teh SH; Khaidizar FD; Ngu LH; Keng WT; Yap S; Mohamed Z
Genes Genomics; 2019 Aug; 41(8):885-893. PubMed ID: 31028654
[TBL] [Abstract][Full Text] [Related]
17. Egyptian glycogen storage disease type III - identification of six novel AGL mutations, including a large 1.5 kb deletion and a missense mutation p.L620P with subtype IIId.
Endo Y; Fateen E; El Shabrawy M; Aoyama Y; Ebara T; Murase T; Podskarbi T; Shin YS; Okubo M
Clin Chem Lab Med; 2009; 47(10):1233-8. PubMed ID: 19754354
[TBL] [Abstract][Full Text] [Related]
18. Mutational analysis of the AGL gene: five novel mutations in GSD III patients.
Lucchiari S; Donati MA; Melis D; Filocamo M; Parini R; Bresolin N; Comi GP
Hum Mutat; 2003 Oct; 22(4):337. PubMed ID: 12955720
[TBL] [Abstract][Full Text] [Related]
19. Molecular analysis of the AGL gene: heterogeneity of mutations in patients with glycogen storage disease type III from Germany, Canada, Afghanistan, Iran, and Turkey.
Endo Y; Horinishi A; Vorgerd M; Aoyama Y; Ebara T; Murase T; Odawara M; Podskarbi T; Shin YS; Okubo M
J Hum Genet; 2006; 51(11):958-963. PubMed ID: 17047887
[TBL] [Abstract][Full Text] [Related]
20. Mutations in exon 3 of the glycogen debranching enzyme gene are associated with glycogen storage disease type III that is differentially expressed in liver and muscle.
Shen J; Bao Y; Liu HM; Lee P; Leonard JV; Chen YT
J Clin Invest; 1996 Jul; 98(2):352-7. PubMed ID: 8755644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
